ASCUS
Understanding ASCUS (Atypical Squamous Cells of Undetermined Significance) in healthcare? This resource provides information on ASC-US, Atypical Squamous Cells of Undetermined Significance diagnosis, clinical documentation, and related medical coding terms for accurate healthcare records. Learn about the significance of ASCUS Pap smear results and relevant medical terminology for effective communication in clinical settings.
Mildly abnormal cervical cells, changes may be HPV or precancerous.
Usually none, may have abnormal Pap smear.
Routine cervical cancer screening (Pap smear).
ICD-10 Code Families
Complete code families applicable to R87.610
When to use each related code
| Description | When to use |
|---|---|
| Mildly abnormal squamous cells. | Use for abnormal squamous cells where the cause is undetermined, favoring benign. |
| Low-grade squamous intraepithelial lesion. | Use for mild dysplasia suggesting HPV infection. Follow-up recommended. |
| High-grade squamous intraepithelial lesion. | Use for moderate to severe dysplasia, a precancerous lesion requiring further investigation. |
Best-practice checklist
- ✓ASCUS Pap smear diagnosis documentation
- ✓Document Bethesda System classification
- ✓Specify squamous cell abnormality
- ✓Rule out high-grade lesions (e.g., HSIL)
- ✓Correlate with HPV test results
- ✓Consider colposcopy/biopsy indications
Common pitfalls to avoid
ASCUS coding requires specifying HPV status (positive, negative, or not tested) for accurate reimbursement and clinical documentation.
If ASCUS is followed by reflex HPV testing, both ASCUS and the HPV test results must be documented and coded.
Accurate coding for ASCUS management (e.g., colposcopy, repeat Pap) is crucial for quality reporting and appropriate follow-up.
Best-practice tips
- 01HPV testing reflex or cotesting for ASCUS.
- 02Document ASC-US with precise cell location.
- 03Consider age and risk factors for ASCUS management.
- 04Adhere to ASCCP guidelines for ASC-US follow-up.
- 05Ensure proper ICD-10 coding for ASCUS diagnosis.
Step-by-step checklist
- 1
Review patient history: HPV, smoking, prior Pap results.
- 2
Confirm adequate specimen cellularity for ASCUS diagnosis.
- 3
Reflex HPV testing if not already performed.
- 4
Document ASCUS interpretation, rationale, and plan.
Ready-to-paste narrative
Patient presents for routine gynecological examination including cervical cancer screening with Pap smear. The patient denies abnormal vaginal bleeding, discharge, or pelvic pain. Past medical history is unremarkable for gynecologic abnormalities. Family history is non-contributory. Physical examination reveals a normal appearing cervix. Pelvic examination is otherwise unremarkable. Pap smear results returned as ASCUS, Atypical Squamous Cells of Undetermined Significance. Differential diagnosis includes low-grade squamous intraepithelial lesion (LSIL) and high-grade squamous intraepithelial lesion (HSIL). Given the ASCUS Pap result, reflexive HPV testing was performed and results are pending. Management will be determined based on HPV results and may include repeat Pap smear, colposcopy, or further diagnostic testing per current guidelines for ASCUS Pap smear management. Patient education provided regarding the significance of ASCUS Pap smear results and the importance of follow-up care. Patient expressed understanding of the plan. ICD-10 code R87.619 used for abnormal Pap smear, unspecified. CPT codes for the Pap smear and HPV testing will be billed accordingly depending on laboratory performed. Follow-up appointment scheduled.
Common questions and answers
What is the recommended ASCUS Pap smear management protocol for a 25-year-old patient with a negative HPV test?+
For a 25-year-old patient with an ASCUS Pap smear result and a negative HPV test, current guidelines recommend routine screening in 3 years. The negative HPV test significantly reduces the risk of underlying high-grade cervical intraepithelial neoplasia (CIN). This approach aligns with the American College of Obstetricians and Gynecologists (ACOG) recommendations, prioritizing a balance between thorough screening and minimizing unnecessary interventions. Explore how HPV testing improves the accuracy of ASCUS Pap smear management and reduces the need for immediate colposcopy.
How do I distinguish between ASCUS and LSIL on Pap smear cytology, and what are the implications for patient management?+
Distinguishing between ASCUS (Atypical Squamous Cells of Undetermined Significance) and LSIL (Low-Grade Squamous Intraepithelial Lesion) on Pap smear cytology can be challenging. ASCUS typically involves mild nuclear abnormalities, while LSIL shows more pronounced nuclear changes and a slightly increased nuclear-to-cytoplasmic ratio, suggestive of HPV infection. While both can indicate HPV infection, LSIL carries a higher likelihood of underlying CIN. Management diverges with ASCUS often warranting HPV testing or repeat cytology, whereas LSIL generally necessitates colposcopy for further evaluation. Consider implementing standardized cytology interpretation criteria within your practice to improve diagnostic accuracy and ensure consistent patient management. Learn more about the cytological features distinguishing ASCUS and LSIL.
When should I refer a patient with ASCUS and a positive high-risk HPV test for colposcopy, and what factors influence this decision?+
A patient with an ASCUS Pap smear result and a positive high-risk HPV test should generally be referred for colposcopy. This combination indicates an increased risk of underlying cervical dysplasia. While age plays a factor, with younger patients sometimes managed expectantly due to high rates of HPV clearance, a positive high-risk HPV test in conjunction with ASCUS typically warrants further investigation. Additional factors influencing the decision include the specific HPV genotype identified, the patient's smoking status, and their immune status. Explore the latest guidelines on managing ASCUS with positive high-risk HPV to ensure appropriate and timely referral for colposcopy.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.